Vaccine order boosts Bavarian Nordic after cancer drug flop
COPENHAGEN (Reuters) - Biotech group Bavarian Nordic said it expected to win more contracts in the United States for its smallpox vaccine after securing an order from the U.S. government stockpile.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Contracts | Government | Health | Smallpox | Smallpox Vaccine | USA Health | Vaccines